Long-Term Donor Chimerism Monitoring for Relapse Risk Assessment After Pediatric Allo-HSCT
Anna Prażmo,1 Paulina Skowera,2 Agnieszka Zaucha-Prazmo,3,* Monika Lejman2,* 1Student Scientific Society of Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, Lublin, Poland; 2Independent Laboratory of Genetic Diagnostics, Medical Univer...
Saved in:
Main Authors: | Prażmo A, Skowera P, Zaucha-Prazmo A, Lejman M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-07-01
|
Series: | The Application of Clinical Genetics |
Subjects: | |
Online Access: | https://www.dovepress.com/long-term-donor-chimerism-monitoring-for-relapse-risk-assessment-after-peer-reviewed-fulltext-article-TACG |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 Vaccine Response in Allo-HSCT Recipients: Insights from a Real-World Prospective Cohort Study
by: Emine Merve Savaş, et al.
Published: (2025-07-01) -
Influence of platelet antigens differences between donor and recipient on neutropenia and thrombocytopenia duration after allogeneic stem cell transplantation
by: L. L. Golovkina, et al.
Published: (2022-11-01) -
Prognostic value of miR-106a and miR-20a in AML patients with chemotherapy or allo-HSCT treatment
by: Yue Liu, et al.
Published: (2025-12-01) -
Application of inhibitor JAK1 and JAK2 ruxolitinib as pre- and posttransplant therapy in patients with myelofibrosis
by: M. V. Barabanshchikova, et al.
Published: (2016-03-01) -
IMPACT OF HLA-DPB1 INCOMPATIBILITY ON THE RESULTS OF ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION FROM HLA-A-B-C–DRB1-DQB1-COMPATIBLE UNRELATED DONOR
by: E. G. Khamaganova, et al.
Published: (2018-05-01)